Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-11-26
1992-11-10
Bond, Robert T.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C07D48722
Patent
active
051625199
ABSTRACT:
This invention provides novel compounds for therapy of tumors susceptible to necrosis when an appropriate compound is administered followed by illumination with light of a wavelength absorbed by the compound, the compounds being dihydro porphyrins of the formula, or the corresponding tetra-hydro porphyrins: ##STR1## where n=1 to 3 and each substituent R, the same or different and at the same or different position in its respective substituent phenyl ring, is an hydroxy group.
REFERENCES:
patent: 4783529 (1988-11-01), Lavallee et al.
patent: 4992257 (1991-02-01), Bonnett et al.
Merck Index [Merck and Co., Rahway, N.J., 1989], p. 172.
Cooper, Spectroscopic Techniques for Organic Chemistry, [New York, J. Wiley and Sons, 1980], p. 243.
Crossley et al., JACS, 1987, 109, 341-348.
Whitlock, JACS, 91(26) 1989 7485-7489.
Berenbaum Morris C.
Bonnett Raymond
Bond Robert T.
Efamol Holdings PLC
Ward E. C.
LandOfFree
Porphyrins and cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porphyrins and cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porphyrins and cancer treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2294960